Esketamine Combo Bests SSRIs for Resistant Depression in Head-to-Head Trial

Esketamine Combo Bests SSRIs for TRD in Head-to-Head Trial

Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than esketamine plus a selective serotonin reuptake inhibitor (SSRI), new research showed. Prior research has suggested that esketamine combined with either antidepressant is effective for TRD. But whether an add-on SNRI would yield […] The post Esketamine Combo…

Esketamine Combo Bests SSRIs for Resistant Depression in Head-to-Head Trial

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone. Medscape Medical News